PubMed · 14054659
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
A H SMITH. 1963. TUBERCULOSIS CONTROL.. https://pubmed.ncbi.nlm.nih.gov/14054659/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
BACKGROUND: The Expanded Program for Immunization (EPI) random walk method has been widely used by the World Health Organization and others for rapid cluster sample surveys where an up-to-date household sampling frame is not available. However, it is not a probability sample, does not allow for population movement since the last census, and does not ensure objectivity in household selection or permit call-backs for non-response. Compact segment sampling avoids these problems and has been proposed as a slower but cleaner alternative. METHODS: We conducted two surveys, one using the EPI scheme and one using compact segment sampling, to estimate vaccination coverage in Western Region of The Gambia within 3 months of each other in 2000-2001. RESULTS: Point estimates for vaccination coverage from the two surveys rarely differed by more than 2%. Any differences were more likely to be due to household selection than to population movement. A simple mathematical model showed that even in extreme situations, ignoring population movement since the last census is unlikely to have any appreciable effect. Rates of homogeneity did not differ systematically between the surveys. CONCLUSIONS: In situations where quality of fieldwork can be guaranteed, the EPI random walk method can give accurate and precise results. However, compact segment sampling is generally to be preferred as it ensures objectivity in household selection and permits the estimation of population totals (such as those unvaccinated), which are helpful for planning service provision.
OBJECTIVE: To investigate the effect of bacillus Calmette-Guerin (BCG) on Toll-like receptors (TLRs) expression and cytokine production in human bladder cancer cell line T24. METHODS: Human transitional carcinoma cell line T24 was cultured in RPMI1640 medium with 10% FBS, BCG was added into the cell culture with various doses in bacteria-cell ratio. After T24 cells were stimulated by BCG for 1 hour, total RNA of cells was extracted. RT-PCR procedure was conducted with the primer of TLR-2 and TLR-4, and the products were analyzed with agarose gels electrophoresis. Then the expression of TLR-2 and TLR-4 in T24 cells was assessed by the analyzing system of gel imaging. After the stimulation culture for 12 hours, the supernatant of cells was collected. The levels of IL-4 and IL-12 in each sample were assayed by ELISA method. RESULTS: The expression level of either TLR-2 or TLR-4 was increased by the stimulation of BCG in a dose-dependent manner, the effects reached the maximal level at the dose of BCG as 10 bacilli per cell. The production of IL-12 in T24 cells was also increased gradually by the stimulation of BCG in a dose-dependent manner, and the dose of BCG obtained maximal effect was 10 bacilli per cell, which is coincident with the results observed in the expression of TLRs. There was no difference showed on the production of IL-4 between T24 cells stimulated with BCG and control. CONCLUSIONS: The stimulation of BCG not only up-regulated the expression of TLR-2 and TLR-4, but also increased the production of IL-12 in bladder cancer T24 cell line. The expression of TLRs and the production of cytokine in bladder cancer cells may be related to the BCG-induced immunol response to human bladder cancer.
The last few years have witnessed intense research on vaccine development against tuberculosis. This has been driven by the upsurge of tuberculosis cases globally, especially those caused by multi-drug-resistant Mycobacterium tuberculosis strains. Various vaccine strategies are currently being developed which can be broadly divided into the so-called living and non-living vaccines. Examples are attenuated members of the M. tuberculosis complex, recombinant mycobacteria, subunit proteins and DNA vaccines. Given current developments, we anticipate that recombinant BCG and DNA vaccines are the most promising. Multiple epitopes of M. tuberculosis may need to be cloned in a vaccine construct for the desired efficacy to be achieved. The technique of assembly polymerase chain reaction could facilitate such a cloning procedure.